Evan A. Elko

455 total citations
16 papers, 217 citations indexed

About

Evan A. Elko is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Evan A. Elko has authored 16 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 2 papers in Infectious Diseases. Recurrent topics in Evan A. Elko's work include Redox biology and oxidative stress (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Glutathione Transferases and Polymorphisms (3 papers). Evan A. Elko is often cited by papers focused on Redox biology and oxidative stress (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Glutathione Transferases and Polymorphisms (3 papers). Evan A. Elko collaborates with scholars based in United States, Netherlands and Italy. Evan A. Elko's co-authors include Yvonne Janssen‐Heininger, Vikas Anathy, Albert van der Vliet, Allison M. Manuel, Cheryl van de Wetering, David J. Seward, Jos van der Velden, Shi Biao Chia, Reem Aboushousha and Ying‐Wai Lam and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Nature Protocols.

In The Last Decade

Evan A. Elko

14 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evan A. Elko United States 8 116 52 36 28 23 16 217
Juergen Gindlhuber Austria 9 85 0.7× 45 0.9× 21 0.6× 16 0.6× 24 1.0× 16 195
Adrianne L. Stefanski United States 9 111 1.0× 66 1.3× 29 0.8× 34 1.2× 70 3.0× 12 269
Shimin Jiang China 9 189 1.6× 46 0.9× 15 0.4× 11 0.4× 22 1.0× 18 291
Caroline Snowden United States 6 124 1.1× 56 1.1× 37 1.0× 27 1.0× 32 1.4× 10 344
Ryoichi Miura Japan 8 65 0.6× 32 0.6× 35 1.0× 40 1.4× 11 0.5× 21 201
Sara Patruno Italy 9 84 0.7× 75 1.4× 48 1.3× 18 0.6× 79 3.4× 10 258
Yasuko Shoji Japan 11 200 1.7× 31 0.6× 34 0.9× 15 0.5× 42 1.8× 28 417
Brad A. Palanski United States 10 116 1.0× 64 1.2× 6 0.2× 19 0.7× 20 0.9× 15 261
Shu Chaing United States 7 206 1.8× 47 0.9× 33 0.9× 74 2.6× 18 0.8× 11 472
Nathalie Donnadieu France 9 51 0.4× 79 1.5× 12 0.3× 24 0.9× 11 0.5× 13 217

Countries citing papers authored by Evan A. Elko

Since Specialization
Citations

This map shows the geographic impact of Evan A. Elko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan A. Elko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan A. Elko more than expected).

Fields of papers citing papers by Evan A. Elko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan A. Elko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan A. Elko. The network helps show where Evan A. Elko may publish in the future.

Co-authorship network of co-authors of Evan A. Elko

This figure shows the co-authorship network connecting the top 25 collaborators of Evan A. Elko. A scholar is included among the top collaborators of Evan A. Elko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan A. Elko. Evan A. Elko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Elko, Evan A., Charles H. D. Williamson, Heather Mead, et al.. (2025). PepSeq as a highly multiplexed platform for melioidosis antigen discovery and vaccine development. Frontiers in Immunology. 16. 1605758–1605758.
2.
Elko, Evan A., et al.. (2024). Recurrent SARS-CoV-2 mutations at Spike D796 evade antibodies from pre-Omicron convalescent and vaccinated subjects. Microbiology Spectrum. 12(2). e0329123–e0329123. 6 indexed citations
3.
Druso, Joseph E., Maximilian B. MacPherson, Shi Biao Chia, et al.. (2024). Endoplasmic Reticulum Oxidative Stress Promotes Glutathione-Dependent Oxidation of Collagen-1A1 and Promotes Lung Fibroblast Activation. American Journal of Respiratory Cell and Molecular Biology. 71(5). 589–602. 2 indexed citations
4.
Bouffard, Nicole A., Evan A. Elko, Anna P. Durbin, et al.. (2024). Localized Inflammation in Dengue Vaccine–Induced Skin Rash Is Not Associated with Continuous Presence of Dengue Virus Genome. Journal of Investigative Dermatology. 145(8). 2021–2033.e3.
5.
Elko, Evan A., et al.. (2024). Mapping disparities in viral infection rates using highly multiplexed serology. mSphere. 9(9). e0012724–e0012724. 1 indexed citations
6.
Elko, Evan A., Yong Liang, Anna Engelbrektson, et al.. (2022). PepSeq: a fully in vitro platform for highly multiplexed serology using customizable DNA-barcoded peptide libraries. Nature Protocols. 18(2). 396–423. 16 indexed citations
7.
Wetering, Cheryl van de, Evan A. Elko, Marijn Berg, et al.. (2021). Glutathione S-transferases and their implications in the lung diseases asthma and chronic obstructive pulmonary disease: Early life susceptibility?. Redox Biology. 43. 101995–101995. 33 indexed citations
8.
Elko, Evan A., Nicolas Chamberlain, R Chandrasekaran, et al.. (2021). Inhibition of PDIA3 in club cells attenuates osteopontin production and lung fibrosis. Thorax. 77(7). 669–678. 28 indexed citations
9.
Elko, Evan A., Allison M. Manuel, Sheryl L. White, et al.. (2021). Oxidation of peroxiredoxin-4 induces oligomerization and promotes interaction with proteins governing protein folding and endoplasmic reticulum stress. Journal of Biological Chemistry. 296. 100665–100665. 30 indexed citations
10.
Aboushousha, Reem, Evan A. Elko, Shi Biao Chia, et al.. (2021). Glutathionylation chemistry promotes interleukin‐1 beta‐mediated glycolytic reprogramming and pro‐inflammatory signaling in lung epithelial cells. The FASEB Journal. 35(5). e21525–e21525. 14 indexed citations
11.
Elko, Evan A., J. Matthew Mahoney, Pamela M. Vacek, et al.. (2019). Age-dependent dysregulation of redox genes may contribute to fibrotic pulmonary disease susceptibility. Free Radical Biology and Medicine. 141. 438–446. 10 indexed citations
12.
Elko, Evan A., Brian Cunniff, David J. Seward, et al.. (2019). Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease. Antioxidants and Redox Signaling. 31(14). 1070–1091. 32 indexed citations
13.
Chia, Shi Biao, Evan A. Elko, Reem Aboushousha, et al.. (2019). Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases. American Journal of Physiology-Cell Physiology. 318(2). C304–C327. 40 indexed citations
14.
Elko, Evan A., et al.. (2018). Ablation of PDIA3 alleviates pulmonary fibrosis in mice. Free Radical Biology and Medicine. 128. S30–S30. 2 indexed citations
15.
Elko, Evan A., Vikas Anathy, Jos van der Velden, Albert van der Vliet, & Yvonne Janssen‐Heininger. (2018). Oxidation state of peroxiredoxin 4 in lungs from patients with pulmonary fibrosis and mouse models of fibrosis. Free Radical Biology and Medicine. 128. S25–S25. 1 indexed citations
16.
Elko, Evan A., Vikas Anathy, Karolyn G. Lahue, et al.. (2017). Role of Peroxiredoxin 4 in Collagen Deposition in Mouse Models of Fibrosis. Free Radical Biology and Medicine. 112. 187–187. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026